Pediococcus acidilactici NX8 and application thereof in degradation of mycotoxin
By screening and identifying Pediococcus acidilactici NX8, a variety of mycotoxin pollution control problems were solved, and efficient degradation of ochratoxin A, vomiting toxin and pyrogenic toxin was achieved, demonstrating the safety and application potential of this strain , enriches the resources for mycotoxin degradation of bacterial strains.
Patent Information
- Application Number
- CN202411387366.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-10-01
- Publication Date
- 2024-11-15
AI Technical Summary
The existing technology lacks research on the degradation of multiple mycotoxins in the control of mycotoxin pollution, and most strains only have a single mycotoxin degradation ability, making it difficult to effectively solve the potential harms of multiple mycotoxin pollution and human and animal husbandry health. .
A strain of Pediococcus lacticococcus acidilactici NX8 was screened and identified. This strain was able to simultaneously degrade ochratoxin A, vomiting toxin and pyrogenic toxin, and its degradation ability and safety were confirmed through morphological and molecular identification.
The mycotoxin degradation rate of strain NX8 reached 96.51%~80.71% for 20μg/mL within 24 hours, and the survival rate was high under different pH and cattle gall salt concentrations, showing excellent gastrointestinal viability and safety. New mycotoxin degradation pathways and resources are provided.
Smart Images

Figure CN118956694A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of microbial degradation, and specifically relates to a strain of Pediococcus acidilactici Pediococcus acidilactici NX8 and its application in degradation of mycotoxins. Background Art
[0002] Mycotoxins are toxic compounds naturally produced by fungi. They have attracted widespread attention due to their potential harmful effects on humans and animals. They are widely found in foods such as grains, oilseeds, nuts, spices and meat. To date, more than 400 mycotoxins have been identified, among which aflatoxin (AF), ochratoxin A (OTA), vomitoxin (DON), fumonisins (FB), zearalenone (ZEN), T-2 toxin (T-2) and patulin (PAT) are the most prevalent toxins with high toxicity in the world. It is reported that the complex dietary habits of humans make people susceptible to exposure to a variety of mycotoxins. The coordinated or cumulative effects of multiple toxins increase health risks and can cause a variety of clinical symptoms such as liver and kidney damage, diarrhea, childhood stunting, and cancer. According to the World Health Organization, 600 million people worldwide suffer from acute toxic diseases and 4.2 million people die from food poisoning every year due to eating food contaminated by pathogenic bacteria, toxins and parasites. Among them, the production and release of mycotoxins in food is one of the most important and dangerous factors affecting human health. Therefore, it is urgent to develop technologies to control mycotoxin contamination.
[0003] Microbial degradation is considered an ideal strategy for controlling mycotoxins. Because it has the ability to specifically degrade mycotoxins, it is harmless to the environment, feed and food safety, has a positive impact on improving the quality of animal products, and can avoid secondary pollution. Microorganisms have been proven to have a positive effect on degrading mycotoxins, but most of the strains reported so far have only studied the degradation ability of a single mycotoxin, and lack research on the degradation of multiple mycotoxins and the harm they cause. Therefore, screening and exploring probiotics that can efficiently degrade multiple mycotoxins is an important means to solve the problem of mycotoxin pollution and prevent harm to animal husbandry and human health. Summary of the invention
[0004] The present invention provides a strain of Pediococcus acidilactici ( Pediococcus acidilactici )NX8, which was deposited in Guangdong Provincial Microbiological Culture Collection Center on August 30, 2024, with the deposit number GDMCC NO:65035, and the deposit address is: Institute of Microbiology, Guangdong Academy of Sciences, 5th Floor, Building 59, No. 100 Xianlie Middle Road, Guangzhou.
[0005] Another object of the present invention is to convert the above-mentioned Pediococcus acidilactici ( Pediococcus acidilactici) NX8 is used in the degradation of mycotoxins, wherein the mycotoxins are one or more of ochratoxin A (OTA), deoxynivalenol (DON), and patulin (PAT).
[0006] The present invention adopts the following technical solutions to achieve the above purpose: 1. After adding PBS buffer to the milk cake purchased in Chenggong District, Kunming City, Yunnan Province, the bacteria were enriched and cultured with MRS liquid medium. The enrichment solution was diluted by gradient, streaked on MRS solid medium, and a single colony was picked; 2. Inoculate a single colony on an MRS solid culture medium containing ochratoxin A, vomitoxin, and patulin to screen and obtain a strain NX8 that can simultaneously degrade ochratoxin A, vomitoxin, and patulin; 3. Identification of strain NX8 (1) Morphological characteristics of strain NX8 The colonies of strain NX8 on MRS solid plates were round, slightly convex, milky white, moist, opaque, with neat edges and smooth surfaces; the bacterial cells were spherical under scanning electron microscopy; (2) Molecular identification The DNA of the isolated and purified strain was extracted and the extracted genome was used as a template. PCR amplification was performed using the 16S rDNA bacterial universal primers 27F: 5'- AGAGTTTGATCCTGGCTCAG -3'; 1429R: 5'- GGTTACCTTGTTACGACTT -3'. The PCR product was sequenced by Meiji (Shanghai) Biopharmaceutical Technology Co., Ltd. The obtained sequence was compared with the sequence on NCBI by BLAST. Based on morphological and molecular identification, the strain NX8 was determined to be Pediococcus acidilactici ( Pediococcus acidilactici ).
[0007] 4. The strain NX8 was used to degrade fungal toxins to detect the degradation efficiency of fungal toxins. Through bile salt resistance and acid resistance test experiments, it was found that the strain NX8 has the ability to withstand gastrointestinal digestion and is edible.
[0008] Advantages and technical effects of the present invention: The invention separates and obtains Pediococcus acidilactici NX8 from fermented dairy products. The bacterium has excellent degradation capabilities of ochratoxin A, vomitoxin and patulin. After 24 hours, the degradation rates of OTA, DON and PAT with a concentration of 20 μg / mL are 96.51%, 79.85% and 80.71% respectively; the survival rates in MRS culture media with pH values of 2, 3 and 4 reach 36.95%, 60.20% and 81.67%; the survival rates in MRS culture media containing 0.1%, 0.3% and 0.5% ox bile salt reach 131.71%, 76.12% and 60.45%. Experimental results show that the strain has strong gastrointestinal survival ability and has the advantage of high safety as a foodborne microorganism. The strain of the invention has great application potential in the aspect of attenuation of medicines, foods and feeds. The invention provides a new way to remove fungal toxin residues in medicines, foods and feeds, enriches the germplasm resource bank of fungal toxin-degrading bacteria and has good market application prospects. BRIEF DESCRIPTION OF THE DRAWINGS
[0009] Figure 1 shows the colony morphology of strain NX8 cultured on MRS solid medium for 1 day; Figure 2 is a scanning electron micrograph of strain NX8; Figure 3 shows the phylogenetic tree of 16S rDNA of strain NX8. DETAILED DESCRIPTION
[0010] The technical scheme of the present invention is further described in detail below in conjunction with specific embodiments and drawings, but the present invention is not limited to the following technical scheme. Unless otherwise specified, the reagents, methods and equipment used in the present invention are conventional reagents, methods and equipment in the technical field. Ordinary technicians in this field can refer to various commonly used reference books, scientific and technological literature or related instructions, manuals, etc. before the filing date of the present invention to implement; MRS liquid medium (1 L): peptone 10 g, beef powder 8 g, yeast powder 4 g, glucose 20 g, sodium acetate trihydrate 5 g, magnesium sulfate heptahydrate 0.2 g, potassium phosphate trihydrate 2 g, ammonium citrate 2 g, manganese sulfate heptahydrate 0.05 g, Tween 80 1 mL; MRS solid medium: add 15-20 g agar powder per 1 L of liquid medium; Example 1: Isolation and identification of strain NX8 1. Screening and isolation of mycotoxin OTA, DON and PAT degrading strains (1) Weigh 5 g of milk cake, add 50 mL of sterile phosphate buffered saline (PBS), mix for 1 h using a rotary shaker (n=150 rpm), take 10 mL of the supernatant and add it to MRS liquid culture medium, culture at 37°C and 150 r / min for 24 h to obtain a bacterial enrichment solution; (2) Use the 10-fold gradient dilution method to dilute the bacterial enrichment solution with sterile water (10 -1 -10 -7 ), spread the dilution on MRS solid medium, incubate at 37°C for 36 h, and after a single colony grows on the plate, pick a representative colony and culture it in 10 mL MRS liquid medium on a shaking table for 24 h to obtain a bacterial solution for subsequent experiments; (3) Streak the bacterial liquid from step (2) onto a screening solid medium (the screening solid medium contains 20 μg / mL OTA, DON, and PAT, respectively), and culture at 37°C for 24 h, then select the strain NX8 that can grow in the screening solid medium containing OTA, DON, and PAT; 2. Identification of strain NX8 (1) Morphological identification The strain NX8 was inoculated on MRS solid plates and inverted for 1 day at 37°C to observe the colony morphology; the colonies cultured on the MRS plate for 1 day were round, slightly convex, milky white, moist, opaque, with neat edges and smooth surfaces ( Figure 1 ), the bacterial cells were observed to be spherical under scanning electron microscopy ( Figure 2 ); (2) 16S rDNA molecular biological identification The bacterial genomic DNA extraction kit (Solebo) was used to extract the genomic DNA of strain NX8. The extraction method was referred to the kit manual. The extracted genomic DNA was used as a template and 16S rDNA bacterial universal primers 27F: 5'-AGAGTTTGATCCTGGCTCAG -3'; 1429R: 5'- GGTTACCTTGTTACGACTT -3' were used for PCR amplification. The PCR product was sequenced by Meiji (Shanghai) Biopharmaceutical Technology Co., Ltd. The measured 16S rDNA sequence was compared and analyzed in the GenBank database using BLAST, and related sequences with higher homology were selected to construct a phylogenetic tree and analyze the evolutionary relationship using MAGE 5.0 software ( Figure 3 ); The 16S rDNA sequence of the strain NX8 isolated and purified by the present invention is similar to that of Pediococcus acidilactici strain 8275, with a homology of 100% and the closest evolutionary distance; combined with morphological characteristics and scanning electron microscopy observation characteristics, strain NX8 was determined to be a lactic acid Pediococcus ( Pediococcus acidilactici ).
[0011] Example 2: Determination of mycotoxin degradation by strain NX8 1. The isolated and purified strain NX8 was cultured in MRS liquid medium at 37°C to obtain 1×10 10 CFU / mL of bacterial suspension; 2. Inoculate the bacterial suspension into 50 mL of MRS liquid culture medium containing 20 mg / mL OTA, DON, and PAT at an inoculation rate of 10%. Set up an MRS medium without mycotoxins as a control group. Each group has six replicates. Culture in a constant temperature shaker at 37°C and 150 rpm for 24 h. Determine the amount of mycotoxins in the MRS liquid culture medium by HPLC, and calculate the degradation rate of mycotoxins OTA, DON, and PAT in 24 h according to the degradation rate formula. Degradation rate (%) = [1-(An / A0)] × 100%, An is the concentration of each toxin in the culture medium after strain NX8 treatment for 24 h, A0 is the initial concentration of each toxin in the culture medium; the results are shown in Table 1; Table 1 Degradation rate of mycotoxins by NX8
[0013] Example 3: Experimental study on the bile tolerance of strain NX8 Take 1 mL, 1×10 10 The bacterial suspension of strain NX8 with a CFU / mL was centrifuged at 7000 r / min for 3 min to collect the bacteria, which were suspended in 10 mL of MRS liquid culture medium containing 0.1%, 0.3%, and 0.5% (m / v) ox bile salts. At the same time, MRS liquid culture medium without ox bile salts was set as a control group; after culturing at 37°C and 150 rpm for 3 h, the number of viable bacteria in each experimental group was counted by the pour plate method; The formula for calculating the bile salt tolerance of the strain is: survival rate (%) = number of viable bacteria in the experimental group / number of viable bacteria in the control group, with six replicates for each treatment. The results are shown in Table 2. The survival rate of strain NX8 reached 131.71% in the medium containing 0.1% ox bile salt, 76.12% in the medium containing 0.3% ox bile salt, and 60.45% in the medium containing 0.5% ox bile salt.
[0014] Table 2 Bile salt tolerance of strain NX8
[0016] Example 4: Acid resistance test of strain NX8 Take 1 mL, 1×10 10The bacterial suspension of strain NX8 (CFU / mL) was centrifuged at 5000 r / min for 5 min to collect the bacteria, which were suspended in 10 mL of MRS liquid medium at pH = 2, pH = 3, and pH = 4. At the same time, MRS liquid medium without pH adjustment was set as the control group. After culturing at 37°C and 150 rpm for 3 h, the number of viable bacteria in each experimental group was counted by the pour plate method. As shown in Table 3, the survival rate of strain NX8 in the medium with pH = 2 reached 36.95%, the survival rate in the medium with pH = 3 reached 60.20%, and the survival rate in the medium with pH = 4 reached 81.67%; Table 3 Acid resistance of strain NX8
[0017] In summary, the strain NX8 of the present invention has excellent ability to degrade ochratoxin A, vomitoxin and patulin, is acid-resistant and bile-resistant, and is safe and edible.
[0018] The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.
Claims
1. A strain of Pediococcus acidilactici ( Pediococcus acidilactici )NX8, whose deposit number in Guangdong Provincial Microbiological Culture Collection Center is GDMCC NO:65035.
2. The use of Pediococcus acidilactici NX8 according to claim 1 in degrading mycotoxins, characterized in that: The mycotoxins are one or more of ochratoxin A, vomitoxin, and patulin.
